Circulatory assist devices and associated infections: new therapies, new complications
DOI:
https://doi.org/10.32818/reccmi.a5n1a13Keywords:
circulatory assist devices, endocarditis, heart failure, antibiotherapy.Abstract
The use of left ventricular assist devices (LVAD) has significantly increased in the past few years. As a result, new complications, such as infections, have emerged. We present the case of the oldest LVAD carrier in our environment. Her cardiovascular disease has significantly improved, although at the cost of recurrent driveline infections and admissions to hospital. Complications associated with the implant of LVAD, such as infections, is a growing and challenging field. An outpatient and multidisciplinary approach might be the key to improve outcomes.
Downloads
Metrics
References
Hanff TC, Birati EY. Left ventricular assist device as destination therapy: a state of the science and art of long-term mechanical circulatory support. Curr Heart Fail Rep. 2019; 16(5): 168-179. https://doi.org/10.1007/s11897-019-00438-x.
Briasoulis A, Inampudi C, Akintoye E, Adegbala O, Alvarez P, Bhama J. Trends in utilization, mortality, major complications, and cost after left ventricular assist device implantation in the United States (2009 to 2014). Am J Cardiol. 2018; 121(10): 1214-1218. https://doi.org/10.1016/j.amj-card.2018.01.041.
Barrio A, Dobarro D, Alzola E, Raposeiras S, González-Santos JM, Sánchez PL. Durable left ventricular assist device therapy in non transplant centers in Spain: initial experience. Rev Esp Cardiol. 2020: S1885-5857(19)30408-6. https://doi.org/10.1016/j.rec.2019.09.025.
Siméon S, Flécher E, Revest M, Niculescu M, Roussel JC, Michel M, et al. Left ventricular assist device-related infections: a multicentric study. Clin Microbiol Infect. 2017; 23(10): 748-751. https://doi.org/10.1016/j.cmi.2017.03.008.
O'Horo JC, Abu Saleh OM, Stulak JM, Wilhelm MP, Baddour LM, Rizwan Sohail M. Left ventricular assist device infections: a systematic review. ASAIO J. 2018; 64(3): 287-294. https://doi.org/10.1097/MAT.0000000000000684.
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001; 345(20): 1435-1443. https://doi.org/10.1056/NEJMoa012175.
Adams EE, Wrightson ML. quality of life with an LVAD: a misunderstood concept. Heart Lung. 2018; 47(3): 177-183. https://doi.org/10.1016/j.hrtlng.2018.02.003.
Mensa J, Soriano A, García Sánchez JE, Marco F, Letang E, Llinares P, et al. Guía terapéutica antimicrobiana. Madrid. Antares, 2020.
Jennings DL, Chopra A, Chambers R, Morgan JA. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices. Artif Organs. 2014; 38(10): 875-879. https://doi.org/10.1111/aor.12254.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 María Sánchez-Ledesma, David González-Calle, Ana Elvira Laffond, Eduardo Villacorta-Argüelles, Javier de-la-Fuente-Aguado
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
